A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications

disease classification of complex and heterogenous diseases, such as acute myeloid leukaemia (AML), is continuously updated to define diagnoses, appropriate treatments, and assist research and education. recent availability of molecular profiling techniques further benefits the classification of AML. the world health organization (WHO) classification of haematolymphoid tumours and the International consensus classification of myeloid neoplasms and acute leukaemia from 2022 are two updated versions of the WHO 2016 classification. as a consequence, the european leukemiaNet 2022 recommendations on the diagnosis and management of AML in adults have been also updated. the current review provides a practical interpretation of these guidelines to facilitate the diagnosis of AML and discusses genetic testing, disease genetic heterogeneity, and FLT3 mutations. we propose a practical algorithm for the speedy diagnosis of AML. future classifications may need to incorporate gene mutation combinations to enable personalised treatment regimens in the management of patients with AML.